Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
As of April 21, 2026, regulatory status for many peptides remains under review and may change as additional data and guidance become available
Provided you are not experiencing side-effects your dose will be increased every four weeks until you reach a maintenance dose of 2.4 mg
Patients on Tirzepatide often achieve even greater results
No, as an experimental senolytic peptide, FOXO4-DRI has no clinical approval or guideline recommendations for human use
Mounjaro and other GLP-1 agonists reduce your appetite, so youll certainly lose weight
US$ 26.11
US$ 20.71
US$ 22.08
US$ 22.68
US$ 20.71
US$ 20.28
